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Algeriaa b s t r a c t
Background: Neural tube defects (NTDs) are severe birth defects, with genetic and/or environmental risk
factors.
Aim: The objective of this study was to analyze data on NTDs cases at the Batna Maternity Hospital and to
investigate some environmental and two genetic risk factors suspected in the etiology of NTDs.
Subjects and methods: This study was conducted on 82 healthy participants and 48 mothers with an NTD
child. Peripheral blood samples were collected, in EDTA tubes and frozen at 20 C until DNA extraction
by conventional method. Genetic analysis of methylene tetrahydrofolate reductase C677T polymorphism
was determined by real time PCR, while cystathionine-beta-synthase 844 insertion was investigated by
traditional PCR. Chi-square analyses were used to evaluate differences in the distribution of data. The
odds-ratio was also calculated. A P-value less than 0.05 were significant.
Results: The incidence of NTD in Batna region was 1.58 per 1000 births. The rate of NTD was significantly
higher in females than males, highest affected NTD newborn’s was observed in mothers aged between 25
and 29 years and the consanguinity among all NTD cases was 30%. Data showed no significant association
of NTDs with personal education, obesity, diabetes, but regarding folic acid consumption, about 86% of
NTD’s mothers in our region didn’t take pre-conceptional supplementation with this vitamin .Genetic fac-
tors results didn’t show a significant association of NTDs with specific mutations of the variant C677T
MTHFR, and no gene-gene interaction of CBS insertion and C677T polymorphism was found, despite a sig-
nificant difference in heterozygote frequency of CBS 844ins68 genotype between NTD’s mothers and con-
trols, OR: 2.85(1.18–6.88).
Conclusion: NTD represents a real public health problem in Batna, Algeria. Various genetic and/or nutri-
tional factors are implicated, although the mechanism is not clear. We suggest that further research
should continue planning for preventive measures and effective treatment to reduce the incidence of
NTDs in Algeria.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neural tube defect (NTD) is a general term for a congenital mal-
formation of the central nervous system occurring secondary to
lack of closure of the neural tube [1] with a worldwide incidence
ranging from 1.0 to 10.0 per 1000 births [2]. Classically, there are
two main groups: (a) anencephaly and encephalocele, and (b)
spina bifida [3] .Anencephaly is fatal in all cases, whereas children
with spina bifida frequently suffer from severe disability and
require continued medical treatment [4].
NTD’s varies by race, geographical location, socioeconomic
class, nutritional status and multiple factors of predisposition witha very high prevalence among the Irish, and low in the black ethnic
groups [5] .NTDs are multifactorial disorders, arising from a com-
plex combination of genetic and environmental interactions
involving nutritional deficiencies, genetic predisposition, in addi-
tion to some trace elements and vitamins that could partially
explain these anomalies [6] .Many studies have investigated the
risk of NTD’ pregnancy for contributions of socioeconomic status
(SES), parental education, maternal and paternal ages and occupa-
tions, smoking, alcoholism, maternal reproductive history, includ-
ing maternal country of birth and country of conception,
hyperthermia during early pregnancy, hyperglycemia, diabetes or
obesity, and maternal use of caffeine and medications during early
pregnancy [2]. Even so, these risk factors are thought to account for
only a small proportion of NTDs, suggesting the presence of other
risk factors [7].
226 R. Bourouba et al. / The Egyptian Journal of Medical Human Genetics 19 (2018) 225–229Due to the known role of folate in NTD prevention [8], consid-
erable research has been focused on genes involved in this vitamin
metabolic pathway; however, few of the corresponding genes have
been associated with an increased risk of NTDs [9]. The MTHFR
gene is the most extensively studied of all the folate metabolism
candidate with 32 published papers, including a wide spectrum
of populations [10]. The MTHFR gene is the main focus of so many
studies, because MTHFR enzyme converts 5, 10-methylene-THF to
5-methyl-THF (5-MTHF), the intracellular form of folate utilized by
both the folate and methionine cycles. The association between
NTDs and the MTHFR C677T polymorphism showed ambiguous
results; the risk was increased for Dutch and Irish populations
[11], in contrast to other populations where no association have
been established [12]. The most studied common mutations in dif-
ferent ethnic populations of the CBS gene in association with NTD
is the 844ins68 insertion [11]. The majority of studies didn’t find a
significant association between NTDs and the CBS gene [13,14]. It
is well established that maternal folic acid supplementation may
reduce the rate of occurrence of anencephaly or Spina bifida in
some populations, but after more than two decades of research,
mechanism (s) by which folic acid may intervene to prevent NTDs
is not fully elucidated [12].
There is no documented study regarding the risk factors of NTDs
in this region of Algeria. Therefore, this study was conducted to
investigate the possible association of the MTHFR C677T polymor-
phism and the CBS 844ins68 in mothers of Batna region, as well as
some environmental factors suspected in the etiology of NTDs.2. Subjects and methods
2.1. Study population and data collection
A retrospective study of children born with a neural tube defect
identified from the Maternity Hospital of Batna, Algeria was con-
ducted within a period of 2 years (2012, 2013), during which more
information was collected for each case, including the age of the
mother, the date of birth, sex; birth single or twins; the residence
and consanguinity. Incidence (birth) rates per 1000 births were
examined for each year of the study period. Furthermore, other
laboratory tests were performed on a group of 82 apparently
healthy participants (control group) and 48 mothers who had con-
ceived a previous NTD child aged between 24 and 48 years, from
Batna Hospital, Algeria. An informed consent for genetic analysis
was obtained from the parents and/or from the individual controls.
Additional data were obtained from NTD’s mothers concerning
medical pre-pregnancy history, personal education, body mass
index (BMI), and folic acid consumption. BMIs 18–25, 25–30, and
>30, were considered as normal, overweight and obesity,
respectively.2.2. DNA samples and genotyping analysis
Peripheral blood samples were collected, in EDTA tubes and fro-
zen at 20 C until their transfer to Ankara/Turkey for DNA extrac-
tion by conventional phenol-chloroform method. After hemolysis
of the blood in hypotonic solution, DNA was isolated by using a
simple proteinase K treatment at 65 C in the presence of SDS, fol-
lowed by ammonium acetate precipitation of debris and ethanol
precipitation of the DNA. DNA amount and purity were quantified
for each sample by spectrophotometry (Nanodrop ND-100).
Genetic analysis of the MTHFR C677T polymorphism was deter-
mined according to an analysis of melting curves performed on the
Light Cycler (Roche 1.5 light Cycler, Mannheim, Germany) in capil-
lary tubes with a detection Kit of this polymorphism (Roche Molec-
ular Biochemicals, Mannheim, Germany). Genotyping of the644ins68 in the CBS gene was analyzed by PCR method in a ther-
mal cycler (Biometra), for the study populations using 5 ml of
10 PCR Buffer, 25 mM MgCl2, 10 mM of dNTP’s mix, 10 pmol of
each primer forward: 50-GCA GTT GTT AAC GGC GGT AT-30 (Fer-
mentas) and reverse 50-GTT GTC TGC TCC GTC TGG TT-30, (Fermen-
tas) and 5 U of Taq polymerase (Fermentas) in a total reaction
volume of 50 ml. PCR conditions were as follows: denaturation at
94 C for 1 min, annealing at 63 C for 1 min, and extension at
72 C for 1 min by 34 cycles, followed by a final extension to
72 C (12 min). A 10 ml aliquot of PCR product was electrophoresed
in a 2% agarose gel stained with ethidium bromide and visualized
under UV light.2.3. Statistical analysis
Chi-square analyses were used to evaluate significant differ-
ences in the distribution of data. A P-value less than 0.05 were con-
sidered as significant. In addition, genotype and allele frequencies
of cases and control subjects were determined and the odds ratios
(OR) as well as their 95% confidence intervals (CI) were calculated
to evaluate the possible association between different genotypes
and NTDs.3. Results and discussion
Neural tube defects (NTDs) are among the most common,
costly, and deadly of all human congenital anomalies whose etiolo-
gies remain largely unknown. The annual incidence of all NTDS
types during the period of study (2012–2013) in the region of
Batna was calculated from Maternity-hospital birth files and the
results from our investigation demonstrated 0.58 and 2.58 NTD
cases per 1000 live births and foetal deaths with an average rate
of 1.58 cases per 1000 births.
Despite widely reported advances, NTDs continue to present a
major public health burden afflicting 1 in 2000 births in the US,
and significantly more births in developing areas such as China
and Latin America [15]. We previously found that the incidence
of NTDs in Setif, Algeria was 7.5 per 1000 births [16]. This high rate
can be attributed to the low dietary folate intake by our female
population [17].
The relatively low prevalence of NTDs in this region of country,
Batna (Algeria) may be due to the awareness by our population of
NTD’s impact or to giving birth in private clinics or early preg-
nancy’s loss of child affected by these anomalies.
Among the cases of NTDs (66.66%) had open spina bifida, 19.5%
had anencephaly, and (5.5%) was affected by encephalocele, and/or
associated – hydrocephalus; however 8.33% had spina bifida asso-
ciated with anencephaly. It has been reported that open or closed
spina bifida is the more frequent NTD malformation with an inci-
dence of 2.6/10,000 [18].
The sex distribution of NTD cases was significantly (p < .05)
higher in females (70%) compared to males (28%). This is in agree-
ment with other studies in southwest Iran [19], and China [20]. On
the other hand, there were non-significant male dominance cases
of NTDs in north of Iran [21], however, in the province of Shanxi
in China, there was no significant difference in the distribution
according to gender [22].
Our study also showed that 30% of children with neural tube
defects are from consanguineous marriage and taking into account
the age of the mothers who had an affected child, the highest rate
(30.6%) were observed in the group aged between 25 and 29 years
without a significant difference (p = 0.41). This is in disagreement
with some researches which showed a linear relationship between
the rate of NTDs and maternal age [23], but also with others where
NTDs were unrelated to age [24]. The observed frequencies of the
Table 2





Odds ratio (95% CI)
Negative insertion 69 (0.81) 33 (0.68) 1
Heterozygous 11 (0.13) 15 (0.31) 2.85 (1.18–6.88)
Homozygous 5 (0.06) 0 (0.01) –
Table 3
Frequency of control and NTD’s mothers for 844ins68 at CBS gene, and homozygous
genotype for MTHFR (TT).
Group 844ins68/TT other genotype’s
combinations
Odds ratio (95%CI)
Controls 3 85 1
NTD’s mothers 2 48 0.59 (0.06–5.83)
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MTHFR gene are shown in Table 1. In the control group, 35 (43%)
were heterozygous (CT) and 14 (17%) were homozygous (TT).
These frequencies were not significantly different (OR = 1.01
(0.42–2.41) from those observed in the NTDs mothers group where
6 (12.5%) were homozygous (TT). In addition, there was no statis-
tically significant difference between allele frequencies for the
MTHFR 677C? T polymorphism in NTDs mothers and control
mothers (OR = 0.7 (0.4–1.19).
Some epidemiological studies have investigated the correlation
of C677T polymorphism in MTHFR gene with several pathological
processes, dependent on the metabolism of folate; like NTDs
[10]. The homozygous C677T MTHFR gene polymorphism shows
an incidence ranging from 10 to 20% in some populations [25].
Our data disagree with another research Carter et al. [26] who
reported a high rate of homozygosity (TT) in mothers with an
NTD child compared with controls. The difference in consumption
of folate and riboflavin in various countries, can explain the associ-
ation with NTDs in some populations and not others [27].
The distribution of different genotypes of CBS 844ins68 poly-
morphism shows that there is a significant difference between
the genotypic frequencies of heterozygous between NTDs mothers
and controls (31 and 13%) for this study population (OR = 2. 85
(1.18–6.88)) Table 2.
These results agree with others [9,12]. In contrast, Grandone
et al. [28], showed an increased risk of NTDs significantly associ-
ated with paternal genotype mutation 844ins68 in the gene of
the CBS, but according to other studies, no significant association
was found between NTD and the CBS gene [13,14].
Single-gene analyses indicate that maternal genes associated
with metabolic conditions (obesity, diabetes) may influence the
risk of neural tube defects (NTDs). However, to our knowledge,
there have been no assessments of maternal-fetal metabolic
gene-gene interactions and NTDs [29].
Our results described in Table 3, show no evidence for a signif-
icant association between the MTHFR polymorphism and CBS
insertion in NTDs mothers compared to controls (OR = 0.59
(0.06–5.83)). In contrast to the study of De Franchis et al. [30] sug-
gesting that the CBS gene variant may occur more frequently in
combination with the MTHFR variant in mothers with an NTD
child, indicating the presence of gene-gene interactions in the eti-
ology of NTDs in some population [31].
As illustrated in Table 4, maternal age, education, obesity, and
consanguineous marriage were not significantly associated with
NTDs in our population. This study showed that there was no sig-
nificant difference between mothers’ age and NTDs, as reported in
the north of Iran [21], whereas in other studies, significant associ-
ation between mothers’ ages and NTDs was found in Russia [32]
and in Turkey [33]. In a meta-analysis study of maternal age as a
risk factor for NTDs, the authors found an increased risk associated
with mothers of 40 years and younger than 19 years [34].
According to our results, the rate of consanguinity among NTD
group is 30% but there is no significant relation between consan-
guineous marriage of parents and NTDs. This agrees with theTable 1





Odds ratio (95% CI)
CC 33 (0.40) 25 (0.52) 1
CT 35 (0.43) 17 (0.35) 0.64 (0.3–1.4)
TT 14 (0.17) 6 (0.125) 1.01 (0.42–2.41)
C 101 (0.62) 67 (0.70) 1
T 63 (0.38) 29 (0.30) 0.7 (0.4–1.19)
* Odds ratio (95% CI) vs. controls.research of Golalipour et al. [21], but others have reported higher
incidence (63.6%) of NTDs with consanguinity in Iraq [35]. We pre-
viously found that the rate of consanguinity among all NTD cases
was 13% in Setif region of Algeria [16]. The possible role that con-
sanguinity could play as a risk factor for NTDs in Algeria requires
further investigations.
The key role that environment play in NTD etiology is high-
lighted by the important impact of maternal nutrition, specifically
folate intake [15]. Similar to our result, several studies reported
significant relation between low folic acid consumption and NTDs
in western Iraq [35], and Austria [36]. However, others demon-
strated a non significant association between folic acid consump-
tion and NTD cases, and this can be due to mandatory flour
fortification with folic acid in this area [21].
Among the most notable environmental risk factors for NTDs
are maternal pre-gestational insulin-dependent diabetes [37] and
maternal pre-pregnancy obesity [38]. Our results showed that obe-
sity is not a risk factor for NTDs (OR = 0.40; 0.42).
Several published studies showed that being overweight in
women was significantly associated with an increase of NTD’s rate
[21]. It is believed that glucose homeostasis plays an important
role in NTD; at the time of neural tube closure, mothers with
poorly regulated glucose levels are likely to have an altered
intrauterine environment leading to abnormal organogenesis
[29]. Maternal variants in the obesity-related genes FTO, LEP, and
TCF7L2 are also associated with NTDs, consistent with maternal
obesity as a risk factor [39].
As reported in our study, mother’s education level was not
related to NTDs, in contrast with other studies in Italy [40] and Tur-
key [33], reporting significant associations between education
level and NTDs. This difference may be due to our small sample
size.4. Conclusion
Most NTDs are sporadic, and their occurrence translates to a
great cost in terms of physical, emotional, and financial burden
of the affected children and their families. Our study confirms that
NTD still represents a real public health problem in Algeria. More-
over, various genetic and/or environmental factors as well as their
complex interactions, nutritional factors like folate deficiency and
seasonal changes in diet, are implicated in the pathogenesis of
NTD in Algeria, although the mechanism is not clear. Etiologic
study of NTDs requires a large base population.
We suggest increased attention to this problem for the develop-
ment of alternative therapies to prevent these defects. This can be
achieved by food fortification in our country to increase a woman’s
Table 4







20–24 17 (20) 10 (20 0.8) 1
25–35 52 (61.17) 27 (56.25) 0.88 0.355–2.19
>35 16 (18.82) 11 (23) 1.17 0.39–3.49
Consanguineous marriage
Yes 25 (30) 15 (31.2) 1
No 60 (70) 33 (68.7) 0.92 0.42–1.97
Body mass index
Normal 35 (41.17) 30(62.5) 1
Overweight 20 (23.52) 7(14.58) 0.40 0.15–1.098
Obese 30 (0.35) 11(23) 0.42 0.18–0.99
Folic acid consumption
Yes 13(15.29) 2 (4.16) 1
No 72 (84.7) 46 (95.83) 4.15 0.89–19.25
Education
Illiterate 6(7) 10(20.83)
Under diplôma 57 (67) 33 (68.75) 0.35 0.11–1.04
Diplôma 22 (26) 5 (30.42) 0.14 0.03–0.55
* OR: odds ratio; CI: confidence interval. Data are presented as No. (%).
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defects registry is essential to the determination of the burden of
these defects in Algeria.Acknowledgments
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